Is SYGGF or GBDC a better dividend investment in 2026?

SYGGF currently yields 2000000.00% with a 5% 5-year dividend growth rate. GBDC yields 11.85% with 5% growth. The better choice depends on your goal: SYGGF offers higher current income.

What is the dividend yield difference between SYGGF and GBDC?

SYGGF has a forward dividend yield of 2000000.00% ($2.00/share annually). GBDC yields 11.85% ($1.50/share annually). The yield gap is 1999988.15 percentage points.

Home › Compare › SYGGF vs GBDC

SYGGF vs GBDC: Dividend Comparison 2026

SYGGF yields 2000000.00% · GBDC yields 11.85%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SYGGF wins by $4.879226400974806e+39M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SYGGF

● Live price

2000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.879226400974806e+39M

Annual income

$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00

Full SYGGF calculator →

GBDC

● Live price

11.85%

Share price

$12.66

Annual div

$1.50

5Y div CAGR

51.1%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.78M

Annual income

$16,389,263.41

Full GBDC calculator →

Portfolio growth — SYGGF vs GBDC

📍 SYGGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SYGGF	GBDC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SYGGF + GBDC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SYGGF pays

GBDC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SYGGF

Annual income on $10K today (after 15% tax)

$170,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr

GBDC

Annual income on $10K today (after 15% tax)

$1,007.11/yr

After 10yr DRIP, annual income (after tax)

$13,930,873.90/yr

At 15% tax rate, SYGGF beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SYGGF + GBDC for your $10,000?

SYGGF: 50%GBDC: 50%

100% GBDC50/50100% SYGGF

Portfolio after 10yr

$2.439613200487403e+39M

Annual income

$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.99%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

SYGGF

Analyst Ratings

Hold

Consensus: Hold

Altman Z

-27.5

Piotroski

1/9

GBDC

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$14.00

+10.6% upside vs current

Range: $13.00 — $15.00

Altman Z

0.6

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SYGGF buys

GBDC buys

No recent congressional trades found for SYGGF or GBDC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSYGGFGBDC

Forward yield	2000000.00% ✓	11.85%
Annual dividend / share	$2.00 ✓	$1.50
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	51.1% ✓
Portfolio after 10y	$4.879226400974806e+39M	$20.78M ✓
Annual income after 10y	$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00 ✓	$16,389,263.41
Total dividends collected	$4.879195005460081e+39M	$20.36M ✓
Payment frequency	quarterly	quarterly
Sector	Stock	BDC
Analyst consensus	Hold	Buy

Year-by-year: SYGGF vs GBDC ($10,000, DRIP)

Year	SYGGF Portfolio	SYGGF Income/yr	GBDC Portfolio	GBDC Income/yr	Gap
1← crossover	$200,010,700	$200,000,000.00	$12,490	$1,790.28	+$200.00M → SYGGF
2	$3,738,731,768,458	$3,738,517,757,009.35	$16,522	$3,157.73	+$3738731.75M → SYGGF
3	$65,315,062,866,930,490	$65,311,062,423,938,240.00	$23,578	$5,898.68	+$65315062866.91M → SYGGF
4	$1,066,400,830,062,625,000,000	$1,066,330,942,945,357,500,000.00	$37,115	$11,886.75	+$1066400830062625.00M → SYGGF
5	$16,272,182,796,453,826,000,000,000	$16,271,041,747,565,660,000,000,000.00	$66,136	$26,423.57	+$16272182796453826560.00M → SYGGF
6	$232,054,240,113,661,900,000,000,000,000	$232,036,828,878,069,680,000,000,000,000.00	$137,257	$66,491.44	+$2.3205424011366188e+23M → SYGGF
7	$3,092,799,066,104,688,500,000,000,000,000,000	$3,092,550,768,067,767,400,000,000,000,000,000.00	$341,734	$194,868.54	+$3.0927990661046884e+27M → SYGGF
8	$38,524,105,697,352,694,000,000,000,000,000,000,000	$38,520,796,402,351,967,000,000,000,000,000,000,000.00	$1,050,788	$685,133.02	+$3.8524105697352695e+31M → SYGGF
9	$448,468,826,014,798,700,000,000,000,000,000,000,000,000	$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00	$4,099,314	$2,974,971.01	+$4.484688260147987e+35M → SYGGF
10	$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000	$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00	$20,775,530	$16,389,263.41	+$4.879226400974806e+39M → SYGGF

SYGGF vs GBDC: Complete Analysis 2026

SYGGF — Stock

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease. The company has a licensing and collaboration agreement with Pharmaxis Ltd. to develop a LOXL2 inhibitor. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.

Full SYGGF Calculator →

GBDC — BDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →

📬

Get this SYGGF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SYGGF vs SCHD SYGGF vs JEPI SYGGF vs O SYGGF vs KO SYGGF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.